二代测序技术在血液肿瘤研究中的应用进展：第56届美国血液学会年会报道

Application of next generation sequencing in the study of hematologic neoplasms： reports from the 56th American Society of Hematology annual meeting

与上届会议相比，第56届美国血液学会（ASH）年会增加了更多的二代测序技术对血液系统疾病的研究，包括疾病的诊断和分型、危险度分层、微小残留病（MRD）的检测、克隆演变、预后以及指导治疗。主要选取几篇具有代表性的文章，概述二代测序技术在血液病研究中的应用进展。

In comparison with the American Society of Hematology （ASH） annual meeting last year, more studies of hematologic malignancies using next generation sequencing （NGS） are published in the 56th ASH meeting this year. NGS was mainly used in the diagnosis and classification, risk stratification, MRD detection, clonal evolution, prognosis and therapy guidance. This short report will address tbe application of NGS in the study of hematologic malignancies by summarizing several representative publications from the 56th ASH meeting.